Search clinical trials for: Injections subcutaneous

Total 3601 results

University of Cincinnati
Patty Brisben Foundation For Women's Sexual Health

Unknown

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

Dyspareunia

United States
Samsung Medical Center

Completed

The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids

Low Back Pain

Korea, Republic of
New Lexington Clinic
St. Joseph's Health Care London

Completed

Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?

Osteoarthritis | Post-traumatic; Arthrosis

United States
Genitope Corporation

Completed

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada
Blumenthal Cancer Center at Carolinas Medical Center

Unknown

High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2

Kidney Cancer

United States
Schön Klinik Berchtesgadener Land
Grifols Therapeutics LLC; Alpha-1 Foundation

Completed

Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients

Chronic Obstructive Pulmonary Disease | Alpha-1-antitrypsin-deficiency

Germany
Shetty-Kim Research Foundation

Unknown

PRP vs HA Intra-articular Knee Injections for Cartilage Defects

Osteoarthritis

United Kingdom
Pfizer

Completed

A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects

Healthy Volunteers

Belgium
Ferring Pharmaceuticals

Completed

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer (IM1)

Prostate Cancer

United States, Canada
The University of Queensland
National Health and Medical Research Council, Australia

Completed

Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia

Musculoskeletal Diseases | Tennis Elbow

Australia
University of California, San Diego
Baxter Healthcare Corporation

Withdrawn

Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design (Hylenex-ED)

Dehydration
MedImmune LLC

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528

Healthy

United States
Cohera Medical, Inc.

Completed

Clinical Trial Comparing Standard Wound Closure Techniques Versus TissuGlu® Surgical Adhesive

Disorder of Skin and/or Subcutaneous Tissue of Trunk

United States
Kathleen Dungan

Completed

Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes

Type 2 Diabetes | Inpatient

United States
Institut de Recherches Cliniques de Montreal
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Taiwan Liposome Company

Completed

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Normal Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

Hematologic Diseases | Iron Overload | Hemoglobinopathies | Thalassemia | Beta-Thalassemia | Hemochromatosis | Anemia (Iron-Loading)
Emory University
Novo Nordisk A/S

Withdrawn

Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care (NOVO ER)

Diabetes
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. (PAP)

Pulmonary Alveolar Proteinosis

China
National Institute of Allergy and Infectious Diseases...

Completed

MVA Post-Event: Administration Timing and Boost Study

Smallpox

United States
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Hoffmann-La Roche

Terminated

A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.

Anemia

Costa Rica, Guatemala, Argentina, Brazil, Panama, Chile, Colombia, Ecuador, Peru, Venezuela
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis

Psoriasis

United States, Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers

Healthy

Germany
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (ZYD1)

Type 2 Diabetes Mellitus

India
Medical University of Vienna

Completed

MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy (MYSTAR-5-YEAR)

Acute Myocardial Infarction

Austria
Eisai Inc.

Completed

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome

United States
Centre Hospitalier Universitaire Dijon

Unknown

AGARIC Case Control Study (AGARIC)

First Recently-diagnosed Colorectal Cancer

France
Kuopio University Hospital

Unknown

ADALISKIAS: Adalimumab for Acute Disc Prolapse

Pain | Disc Prolapse

Finland
National Institute of Allergy and Infectious Diseases...
Warner Lambert - Parke Davis

Completed

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

HIV Infections | Tuberculosis

United States
Johann Wolfgang Goethe University Hospital

Unknown

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

Germany
Alcon Research

Terminated

Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

Macular Degeneration

United States
Bio-ker S.r.l.
Cross Research S.A.; Nerviano Medical Sciences; AAI Deutschland GmbH & Co. KG; Gife...

Completed

Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen®

Healthy Male Subjects

Switzerland
Centocor, Inc.
Schering-Plough

Completed

Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

China
Pfizer

Completed

A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

Macular Edema | Retinal Disease | Diabetic Mellitus

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects

Hypercholesterolemia

United Kingdom
Pain Management Center of Paducah

Completed

Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain

Low Back Pain

United States
Novartis Pharmaceuticals

Withdrawn

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Psoriasis
EMD Serono

Completed

A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies

Infertility | Ovarian Stimulation
Human Genome Sciences Inc.
GlaxoSmithKline

Terminated

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States, Mexico
EMD Serono
Merck Serono International SA

Completed

Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects

Multiple Sclerosis, Relapsing-remitting
Favrille

Terminated

Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
CSL Behring

Completed

A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)

Multifocal Motor Neuropathy (MMN)

Switzerland, Italy, United Kingdom
OAD Orthopaedics

Terminated

Effectiveness of a Knee Brace When Combined With Viscosupplementation in the Treatment of Knee Osteoarthritis

Knee Osteoarthritis

United States
SironRX Therapeutics, Inc.

Unknown

Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

Median Sternotomy

United States
Palatin Technologies, Inc

Completed

Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension

Hypertension
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis (GO-REVEAL)

Arthritis, Psoriatic

United States, Poland, United Kingdom, Spain, Canada, Belgium
Centocor, Inc.
Schering-Plough

Completed

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

Spondylitis, Ankylosing

United States, Germany, Finland, Taiwan, Korea, Republic of, Canada, Belgium, Netherlands, France
Alaunos Therapeutics

Completed

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Melanoma

United States
Klinikum Klagenfurt am Wörthersee

Completed

Subcutaneous Adaption and Cosmetic Outcome Following Caesarean Delivery

Caesarean Delivery

Austria

3

Subscribe